Intercept Pharmaceuticals



Ebitda Zmiana Data
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Alnylam Pharmaceuticals USD 381.78M 362.95M 2025-09
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.14B 775M 2025-12
Arrowhead Research USD 64.2M 223.53M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
Biogen USD 573.2M 253.7M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Esperion Therapeutics USD -27.51M 9.5M 2023-09
Galectin Therapeutics USD -7.42M 819K 2021-12
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Incyte USD 506.92M 74.6M 2025-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Moderna USD -208M 552M 2025-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 5.88B 290M 2025-09
PTC Therapeutics USD -33.11M 1B 2025-06
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


Intercept Pharmaceuticals - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.